This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Griffith University, Nationwide Children's Hospital. Active years: 2026.
Company Filing History:
1 out of 36 
1 out of 179 
Years Active: 2026
Title: Johnson Mak - Innovator in Pathogen Modulation
Introduction
Johnson Mak is an inventor based in Nathan, Queensland, Australia. He has made significant contributions to the field of pathogen modulation through his research and innovative ideas. Although he currently holds no granted patents, his work is noteworthy and reflects his dedication to advancing scientific knowledge.
Latest Patent Applications
Johnson Mak's latest patent application is titled "Agents and Methods for Modulating Pathogen Activity." This application relates to the use of ligands of complement receptor 3, including ligands of the I domain of the alpha subunit of this receptor. The methods, compositions, and devices described aim to inhibit the interaction of pathogens with complement receptor 3-expressing cells and to treat or inhibit the development of infections caused by such pathogens.
Conclusion
Johnson Mak's innovative research in pathogen modulation showcases his commitment to addressing critical health challenges. His contributions, although not yet reflected in granted patents, hold promise for future advancements in the field.